Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caroverine Transtympanic Treatment for Tinnitus
NCT01174979Phase 3Suspended
- Sponsor
- Phafag
- Start
- Jan 2011
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of caroverine in tinnitus, sponsored by Phafag. Started Jan 2011; status: suspended.
02
Drugs
caroverine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT01174979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174979.